2013Medical Innovation of ChinaRequires access

Curative Effect Observation of Sildenafil Citrate Effecting on Pulmonary Hypertension Secondary to Congenital Heart Disease

Jinyuan Wang

Open publisher page 0 citations

Abstract

Objective:To explore clinical therapeutic effect of sildenafil treatment of congenital heart disease(CHD)combined pulmonary arterial hypertension(PAH).Method:Selected 50 cases of CHD merge PAH cases,divided into the research group and the control group,the control group given conventional treatment,the research group on the basis of the given oral sildenafil treatment,observed the treatment effect of two group.Result:After treatment group patients PAP decline degree and PaO 2 and oxygenation index rising degree,were significantly superior to control group.No found that obvious adverse reaction.Conclusion:Sildenafil treatment of CHD merger PAH,which can effectively reduce the pulmonary artery pressure,and improve heart function of patients,and no bad reaction,high safety.

About this research paper

What this paper is about

Objective:To explore clinical therapeutic effect of sildenafil treatment of congenital heart disease(CHD)combined pulmonary arterial hypertension(PAH).Method:Selected 50 cases of CHD merge PAH cases,divided into the research group and the control group,the control group given conventional treatment,the research group on the basis of the given oral sildenafil treatment,observed the treatment effect of two group.Result:After treatment group patients PAP decline degree and PaO 2 and oxygenation index rising degree,were significantly superior to control group.No found that obvious adverse reaction.Conclusion:Sildenafil treatment of CHD merger PAH,which can effectively reduce the pulmonary artery pressure,and improve heart function of patients,and no bad reaction,high safety.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore clinical therapeutic effect of sildenafil treatment of congenital heart disease(CHD)combined pulmonary arterial hypertension(PAH).Method:Selected 50 cases of CHD merge PAH cases,divided into the research group and the control group,the control group given conventional treatment,the research group on the basis of the given oral sildenafil treatment,observed the treatment effect of two group.Result:After treatment group patients PAP decline degree and PaO 2 and oxygenation index rising degree,were significantly superior to control group.No found that obvious adverse reaction.Conclusion:Sildenafil treatment of CHD merger PAH,which can effectively reduce the pulmonary artery pressure,and improve heart function of patients,and no bad reaction,high safety.

Key concepts: Sildenafil, Medicine, Pulmonary hypertension, Pulmonary artery, Cardiology, Internal medicine, Heart disease, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Curative Effect Observation of Sildenafil Citrate Effecting on Pulmonary Hypertension Secondary to Congenital Heart Disease — Research Paper | ScholarLens